NIAID Marks HIV Vaccine Awareness Day 2024

Featured News

In observance of HIV Vaccine Awareness Day on Saturday, May 18, NIAID expresses its gratitude to the dedicated global community of scientists, advocates, study participants, study staff, and funders working toward a safe, effective, durable, and accessible HIV vaccine. 

Click here to read the full article.
HIV Vaccine

Latest News

A needle withdraws the vaccine in an RSV vial.
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
mpox virus particles from NIAID Integrated Research Facility (credit: NIAID)
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Latest news about the results of the COVAIL trial regarding the Sanofi booster. GW participated as one of the many sites for this COVID-19 vaccine study.